Compare the 9 manufacturers holding an active US Drug Master File for Vasopressin API, with DMF numbers and filing years from the FDA's quarterly DMF list.
Directory listing last reviewed October 2026.
9 manufacturers hold an active Type II Drug Master File for VasopressinAPI, taken from the FDA's quarterly DMF list; 8 of them are listed in this directory. A DMF lets a drug applicant reference the maker's manufacturing data. It is not an FDA approval. Check each manufacturer against the FDA import alert lists before ordering.
| Manufacturer | Location | US DMF | Filed |
|---|---|---|---|
| BCN Peptides | Spain (Barcelona) | 25736 | 2012 |
| Bachem Holding AG | Switzerland / USA | 28532 | 2014 |
| PolyPeptide Group | Global | 32116 | 2017 |
| Piramal Pharma Solutions | India (Mumbai) | 32146 | 2017 |
| Auro Peptides | India (Hyderabad) | 33119 | 2018 |
| Hainan Shuangcheng Pharmaceuticals | China (Haikou) | 37634 | 2022 |
| Hetero | India (Hyderabad) | 42073 | 2025 |
| HLB PEP (formerly AnyGen) | South Korea | 44390 | 2026 |
Not yet listed in this directory, so we have not reviewed them. Names as printed in the FDA DMF list.
| DMF holder | US DMF | Filed |
|---|---|---|
| International Medication Systems Ltd | 32769 | 2018 |
Request API quotes from several manufacturers at once. Hold a Vasopressin DMF and not listed? Add your company.